Related Experiment Video
Updated: Jun 20, 2026
07:40
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Exploiting synthetic lethal interactions for targeted cancer therapy.
H Christian Reinhardt1, Hai Jiang, Michael T Hemann
1The Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
Cell Cycle (Georgetown, Tex.)
|September 17, 2009
Summary
Synthetic lethality exploits DNA repair vulnerabilities in cancer cells with specific gene mutations. This approach targets tumor cells for preferential killing, offering a promising new cancer therapy strategy.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cancer cells often harbor mutations in oncogenes and tumor suppressor genes.
- DNA damage signaling and repair pathways are crucial for cell survival.
- Exploiting vulnerabilities in these pathways presents a therapeutic opportunity.
Purpose of the Study:
- To review the concept of synthetic lethality in cancer.
- To highlight recent successful implementations of synthetic lethality.
- To discuss its therapeutic potential in targeting tumor cells.
Main Methods:
- Literature review of synthetic lethality research.
- Analysis of studies demonstrating synthetic lethality in cancer models.
- Examination of clinical applications in human cancer patients.
Main Results:
- Synthetic lethal interactions can be identified between mutated genes and DNA repair pathways.
- Successful targeting of tumor cells using synthetic lethality has been demonstrated in vitro and in vivo.
- Clinical applications show promise in treating human cancers.
Conclusions:
- Synthetic lethality is a viable strategy for cancer therapy.
- Targeting DNA damage response pathways offers a way to selectively kill cancer cells.
- Further research and clinical translation are warranted.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:26Protein Networks
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...